Research measuring inflammatory markers shows the combination lowers pro-inflammatory cytokines (IL-6, TNF-alpha) by 6080%, versus 3040% for either peptide alone translating to less pain, less swelling, and a faster return to function without sacrificing healing quality
Clinical Benefits Specifically stimulates growth hormone without affecting cortisol, prolactin, or ACTHavoiding unwanted hormonal side effects common with older peptides
Nutrition Research, 99 , 4050
Obesity Treatment and Fat Loss: Obese mouse models treated with SLU-PP-332 lost approximately 12 percent of their total body weight, gained 10 times less fat than untreated mice, and showed improvements in glucose metabolism and insulin sensitivity while maintaining a stable appetite
GLP-1 RAs may also reduce the number of dermal -T cells and IL-17 mRNA expression in psoriasis plaques in patients with diabetes [13, 22]
Uncover macros and micros vetted on 75+ parameters: Get instant access to report The escalating prevalence of chronic metabolic disorders, particularly Type 2 Diabetes Mellitus (T2DM), is directly linked to the increasing demand for Semaglutide as a therapeutic option